(Q41531492)

2 October 2017

1 reference

title

Achieving sustained improvement in myocardial perfusion: role of isosorbide mononitrate (English)

1 reference

2 October 2017

H C Lewin

1

1 reference

2 October 2017

D S Berman

series ordinal

2

1 reference

2 October 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

American Journal of Cardiology

2 October 2017

published in

1 reference

2 October 2017

volume

79

1 reference

2 October 2017

issue

12B

1 reference

2 October 2017

page(s)

31-35

1 reference

Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina: a comparison with a continuous schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Transdermal nitroglycerin patch therapy reduces the extent of exercise-induced myocardial ischemia: results of a double-blind, placebo-controlled trial using quantitative thallium-201 tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Sequential thallium-201 myocardial perfusion studies after successful percutaneous transluminal coronary artery angioplasty: delayed resolution of exercise-induced scintigraphic abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Technetium 99m sestamibi in the assessment of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Clinical applications of exercise nuclear cardiology studies in the era of healthcare reform

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Noninvasive identification of myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiograms with technetium-99m-Sestamibi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Exercise, electrocardiographic and functional responses after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Exercise electrocardiography and myocardial scintigraphy in the serial evaluation of the results of percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Short- and long-term changes in myocardial perfusion after percutaneous transluminal coronary angioplasty assessed by thallium-201 exercise scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Effects of long-term treatment with 120 mg of sustained-release isosorbide dinitrate and 60 mg of sustained-release nifedipine on myocardial perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Beneficial actions of nitrates in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Preferential dilation of recipient coronary arteries of the collateral circulation by intracoronary administration of nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Significance of collateral circulation in reversible left ventricular asynergy by nitroglycerin in patients with relatively recent myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 single photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Coronary vasomotor responses: role of endothelium and nitrovasodilators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Update on nitrate tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Nitrate tolerance and dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Chronic stable angina pectoris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Ointments and transdermal nitroglycerin patches for stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Short and long-acting oral nitrates for stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Reproducibility of stress redistribution thallium-201 SPECT quantitative indexes of hypoperfused myocardium secondary to coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

Nitrate therapy and the development of tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900383-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(97)00383-4

1 reference

2 October 2017

1 reference